Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $3.33 Million - $5.22 Million
55,700 Added 1638.24%
59,100 $3.9 Billion
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $944,160 - $1.06 Million
-11,200 Reduced 76.71%
3,400 $314 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $1.06 Million - $1.4 Million
14,600 New
14,600 $1.4 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.